Federated Hermes’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,664
Closed -$288K 2202
2024
Q2
$288K Buy
10,664
+9,663
+965% +$201K ﹤0.01% 1420
2024
Q1
$18.3K Sell
1,001
-470,776
-100% -$7.47M ﹤0.01% 1734
2023
Q4
$5.79M Buy
+471,777
New +$4.42M 0.01% 681
2023
Q1
Sell
-1
Closed -$53 2292
2022
Q4
$53 Buy
+1
New +$49 ﹤0.01% 2131
2021
Q1
Sell
-141,432
Closed -$8.91M 2366
2020
Q4
$8.91M Sell
141,432
-69,313
-33% -$4.3M 0.02% 675
2020
Q3
$14.2M Buy
+210,745
New +$11.5M 0.03% 488
2020
Q1
Sell
-120,900
Closed -$4.88M 2379
2019
Q4
$4.88M Buy
120,900
+20,900
+21% +$732K 0.01% 780
2019
Q3
$3.25M Hold
100,000
0.01% 883
2019
Q2
$4.85M Buy
+100,000
New +$4.25M 0.01% 791

Other funds holding SILK

Federated Hermes's SILK Position: Q3 2024 in Review

Federated Hermes sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 10,664 shares — an estimated $288K sold.

Federated Hermes first reported a position in SILK in Q2 2019 and held it in 9 quarters. The position peaked at $14.2M in Q3 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Federated Hermes reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Federated Hermes sold 10,664 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $288K.
  • Federated Hermes first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
  • Federated Hermes's Silk Road Medical, Inc. Common Stock position peaked at $14.2M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Federated Hermes's 13F filing for Q3 2024, filed 13 Nov 2024.